No Prescription |
 |
 | ||
|
RIBAVIN Ribavirin |
|
| ||
No Prescription » Prescription Drugs 14 » RIBAVIN Ribavirin Ribavirin is used with another medication called an interferon to treat hepatitis C. Ribavirin is in a class of antiviral medications called nucleoside analogues. It works by stopping the virus that causes hepatitis C from spreading inside the body. It is not known if treatment that includes ribavirin and another medication cures hepatitis C infection prevents liver damage that may be caused by hepatitis C or prevents the spread of hepatitis C to other people.Ribavirin comes as a tablet a capsule and an oral solution (liquid) to take by mouth. It is usually taken twice a day in the morning and the evening for 24-48 weeks or longer. Take ribavirin tablets with food. Take ribavirin capsules and oral solution with food unless your doctor tells you that you may take ribavirin with or without food. In that case be sure to take the medication the same way every day. It is best to take ribavirin at around the same times every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take ribavirin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Shake the liquid well before each use to mix the medication evenly. Be sure to wash the measuring spoon or cup after use each time you measure the liquid.Your doctor may decrease your dose or tell you to stop taking ribavirin for a short time if you develop side effects of the medication. Call your doctor if you are bothered by side effects of ribavirin. Do not decrease your dose or stop taking ribavirin unless your doctor tells you that you should.Ribavirin is also sometimes used to treat viral hemorrhagic fevers (viruses that can cause bleeding inside and outside of the body problems with many organs and death). In the event of biological warfare ribavirin may be used to treat viral hemorrhagic fever that has been spread deliberately. Ribavirin is also sometimes used to treat severe acute respiratory syndrome (SARS; a virus that may cause breathing problems pneumonia and death). Talk to your doctor about the possible risks of using this drug for your condition. Buy RIBAVIN Ribavirin and other Prescription Drugs 14 products online at Medstore. 931
About RIBAVIN Ribavirin: Product Type: Prescription Drugs 14 RIBAVIN ( Ribavirin Rebetol Generic Ribavirin ) RIBAVIN (Ribavirin Rebetol Generic Ribavirin) Rebetol Generic Ribavirin 200mg Caps 40 (10 x 4) Ribavirin Rebetol Generic Ribavirin RIBAVIN
View more Prescription Drugs 14 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
